Esophageal cancer epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
==Epidemiology and Demographics==
Esophageal cancer is a relatively rare form of cancer, but some world areas have a markedly higher incidence than others: China, India and Japan, as well as the United Kingdom, appear to have a higher incidence, as well as the region around the Caspian Sea.<ref name=Stewart>Stewart BW, Kleihues P (editors). ''World cancer report''. Lyon: [[International Agency for Research on Cancer|IARC]], 2003. ISBN 92-832-0411-5.</ref>
Esophageal cancer is a relatively rare form of cancer, but some world areas have a markedly higher incidence than others: China, India and Japan, as well as the United Kingdom, appear to have a higher incidence, as well as the region around the Caspian Sea.<ref name=Stewart>Stewart BW, Kleihues P (editors). ''World cancer report''. Lyon: [[International Agency for Research on Cancer|IARC]], 2003. ISBN 92-832-0411-5.</ref>


Line 12: Line 11:


Multiple reports indicate that esophageal adenocarcinoma incidence has increased during the past 20 yr, especially in non-Hispanic white men. Esophageal adenocarcinoma age-adjusted incidence increased in New Mexico from 1973 to 1997. This increase was found in non-Hispanic whites and Hispanics and became predominant in non-Hispanic whites. <ref name=synergy>{{cite web | author = Kenneth J. Vega, M.D., M. Mazen JamaM.D.l | title =Changing pattern of esophageal cancer incidence in New Mexico | work =Changing pattern of esophageal cancer incidence in New Mexico | url=http://www.blackwell-synergy.com/doi/abs/10.1111/j.1572-0241.2000.02329.x?cookieSet=1&journalCode=ajg | year = 2000 | month= Sep | publsiher=The American Journal of Gastroenterology | accessdate=2007-03-21}}</ref>
Multiple reports indicate that esophageal adenocarcinoma incidence has increased during the past 20 yr, especially in non-Hispanic white men. Esophageal adenocarcinoma age-adjusted incidence increased in New Mexico from 1973 to 1997. This increase was found in non-Hispanic whites and Hispanics and became predominant in non-Hispanic whites. <ref name=synergy>{{cite web | author = Kenneth J. Vega, M.D., M. Mazen JamaM.D.l | title =Changing pattern of esophageal cancer incidence in New Mexico | work =Changing pattern of esophageal cancer incidence in New Mexico | url=http://www.blackwell-synergy.com/doi/abs/10.1111/j.1572-0241.2000.02329.x?cookieSet=1&journalCode=ajg | year = 2000 | month= Sep | publsiher=The American Journal of Gastroenterology | accessdate=2007-03-21}}</ref>
==Epidemiology and Demographics==
===Prevalence===
* In the United States, the [age adjusted] prevalence of (insert disease name here) is _____ % in 2011.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
===Incidence===
* The delay-adjusted incidence of (insert disease name here) in 2011 was estimated to be _____ per 100,000 persons in the United States.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
* In 2011, the age-adjusted incidence of (insert disease name here) was _____ per 100,000 persons in the United States.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
===Age===
* While the overall age adjusted incidence of (insert disease name here) in the United States between 1975 and 2011 is _____ per 100,000, the age-adjusted incidence of (insert disease name here) by age category is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
** Under 65 years: _____ per 100,000
** 65 and over: _____ per 100,000
===Gender===
* In the United States, the [age adjusted] prevalence of (insert disease name here) by gender in 2011 is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
** In females: _____ %
** In males: _____ %
* In the United States, the delay-adjusted incidence of (insert disease name here) by gender in 2011 is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
** In females: _____ per 100,000 persons
** In males: _____ per 100,000 persons
* In the United States, the age-adjusted incidence of (insert disease name here) by gender on 2011 is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
** In females: _____ per 100,000 persons
** In males: _____ per 100,000 persons
Shown below is an image depicting the delay-adjusted incidence of (insert disease name here) by gender and race in the United States between 1975 and 2011.
[Insert figure x.1 from the report]
===Race===
* Shown below is a table depicting the [age adjusted] prevalence of (insert disease name here) by race in 2011 in the United States.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
{| style="cellpadding=0; cellspacing= 0; width: 600px;"
|-
|style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center | || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''All Races''' ||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''White''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Black''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Asian/Pacific Islander'''  || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''American Indian/Alaska Native'''  || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Hispanic'''
|-
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Age-adjusted prevalence'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |  ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |  ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |  ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |  ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |  ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |
|}
* In the United States, the race that is most susceptible to developing this disease/condition, is the ____ race.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
Shown below is an image depicting the incidence of (insert disease name here) by race in the United States between 1975 and 2011.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
[Insert figure x.2 from the report]
===Percent Distribution of (insert disease name here) by Histology===
* Among patients with histologically confirmed cases of (insert disease name here), the percent distribution of the types of the disease between 2004 and 2010 in the United States are:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
**  Type X: _____ %
** Type Y: _____ %
** Type Z: _____ %


==References==
==References==

Revision as of 13:45, 11 June 2014

Esophageal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Esophageal cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esophageal cancer epidemiology and demographics On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esophageal cancer epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esophageal cancer epidemiology and demographics

CDC on Esophageal cancer epidemiology and demographics

Esophageal cancer epidemiology and demographics in the news

Blogs on Esophageal cancer epidemiology and demographics

Directions to Hospitals Treating Esophageal cancer

Risk calculators and risk factors for Esophageal cancer epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Esophageal cancer is a relatively rare form of cancer, but some world areas have a markedly higher incidence than others: China, India and Japan, as well as the United Kingdom, appear to have a higher incidence, as well as the region around the Caspian Sea.[1]

The American Cancer Society estimates that during 2007, approximately 15,560 new esophageal cancer cases will be diagnosed in the United States.[2]

The esophageal cancer incidence and mortality rates for people of African-Americans have been higher than the rate for Caucasians. [3] According to the NCI, incidence of adenocarcinoma of the esophagus, which is associated with Barrett's esophagus, is rising in the United States. This type is more common in Caucasian men over the age of 60.

Multiple reports indicate that esophageal adenocarcinoma incidence has increased during the past 20 yr, especially in non-Hispanic white men. Esophageal adenocarcinoma age-adjusted incidence increased in New Mexico from 1973 to 1997. This increase was found in non-Hispanic whites and Hispanics and became predominant in non-Hispanic whites. [4]

Epidemiology and Demographics

Prevalence

  • In the United States, the [age adjusted] prevalence of (insert disease name here) is _____ % in 2011.[5]

Incidence

  • The delay-adjusted incidence of (insert disease name here) in 2011 was estimated to be _____ per 100,000 persons in the United States.[5]
  • In 2011, the age-adjusted incidence of (insert disease name here) was _____ per 100,000 persons in the United States.[5]

Age

  • While the overall age adjusted incidence of (insert disease name here) in the United States between 1975 and 2011 is _____ per 100,000, the age-adjusted incidence of (insert disease name here) by age category is:[5]
    • Under 65 years: _____ per 100,000
    • 65 and over: _____ per 100,000

Gender

  • In the United States, the [age adjusted] prevalence of (insert disease name here) by gender in 2011 is:[5]
    • In females: _____ %
    • In males: _____ %
  • In the United States, the delay-adjusted incidence of (insert disease name here) by gender in 2011 is:[5]
    • In females: _____ per 100,000 persons
    • In males: _____ per 100,000 persons
  • In the United States, the age-adjusted incidence of (insert disease name here) by gender on 2011 is:[5]
    • In females: _____ per 100,000 persons
    • In males: _____ per 100,000 persons

Shown below is an image depicting the delay-adjusted incidence of (insert disease name here) by gender and race in the United States between 1975 and 2011.

[Insert figure x.1 from the report]

Race

  • Shown below is a table depicting the [age adjusted] prevalence of (insert disease name here) by race in 2011 in the United States.[5]
All Races White Black Asian/Pacific Islander American Indian/Alaska Native Hispanic
Age-adjusted prevalence
  • In the United States, the race that is most susceptible to developing this disease/condition, is the ____ race.[5]

Shown below is an image depicting the incidence of (insert disease name here) by race in the United States between 1975 and 2011.[5]

[Insert figure x.2 from the report]

Percent Distribution of (insert disease name here) by Histology

  • Among patients with histologically confirmed cases of (insert disease name here), the percent distribution of the types of the disease between 2004 and 2010 in the United States are:[5]
    • Type X: _____ %
    • Type Y: _____ %
    • Type Z: _____ %

References

  1. ↑ Stewart BW, Kleihues P (editors). World cancer report. Lyon: IARC, 2003. ISBN 92-832-0411-5.
  2. ↑ "What Are the Key Statistics About Cancer of the Esophagus?". Detailed Guide: Esophagus Cancer. 2006. Retrieved 2007-03-21. Unknown parameter |publsiher= ignored (|publisher= suggested) (help); Unknown parameter |month= ignored (help)
  3. ↑ "Incidence and Mortality Rate Trends" (PDF). A Snapshot of Esophageal Cancer. 2006. Retrieved 2007-03-21. Unknown parameter |publsiher= ignored (|publisher= suggested) (help); Unknown parameter |month= ignored (help)
  4. ↑ Kenneth J. Vega, M.D., M. Mazen JamaM.D.l (2000). "Changing pattern of esophageal cancer incidence in New Mexico". Changing pattern of esophageal cancer incidence in New Mexico. Retrieved 2007-03-21. Unknown parameter |publsiher= ignored (|publisher= suggested) (help); Unknown parameter |month= ignored (help)
  5. ↑ 5.00 5.01 5.02 5.03 5.04 5.05 5.06 5.07 5.08 5.09 5.10 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Esophageal_cancer_epidemiology_and_demographics&oldid=977319"